NCT00703833已完成2 期
A Double-Blind, Multicenter, Placebo-Controlled Study of MK0777 Gel Extrusion Module (GEM) 1.5 mg b.i.d. in the Treatment of Outpatients With Generalized Anxiety Disorder
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 51
- 主要终点
- Measure the reduction of anxiety
研究概览
简要总结
The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or Female
- •Current diagnosis of Generalized Anxiety Disorder
- •Age 18 - 70
排除标准
- •Women who are pregnant, or breast-feeding
- •Use of illicit drugs
- •History of drug or alcohol dependence
研究组 & 干预措施
1
Experimental
Drug
干预措施: MK0777 (Drug)
2
Placebo Comparator
Placebo
干预措施: Placebo (unspecified) (Drug)
结局指标
主要结局
Measure the reduction of anxiety
时间窗: after 4 weeks and at end of study
次要结局
- Safety and efficacy(throughout study and at end of study)
研究者
相似试验
已完成
4 期
A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety DisorderAnxiety Disorders,Generalized Anxiety DisorderNCT03924323AbbVie273
已完成
2 期
A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)Anxiety DisordersNCT00543920Merck Sharp & Dohme LLC60
已完成
2 期
Treatment of Patients With Anxiety Disorder (0777-022)Generalized Anxiety DisorderNCT00539578Merck Sharp & Dohme LLC270
已完成
3 期
Experimental Medication For the Treatment of Generalized Anxiety DisorderAnxiety DisorderNCT00097708Jazz Pharmaceuticals511
已完成
2 期
Combined Treatment for Generalized Anxiety Disorder (GAD)Generalized Anxiety DisorderNCT00620776University of Pennsylvania69